✦ LIBER ✦

IFN plus ribavirin and amantadine for IFN-insensitive patients with chronic hepatitis C: Results of a multicenter, randomized, controlled trial

✍ Scribed by P. Andreone; A. Gramenzi; C. Cursaro; C. Pirraglia; G. Verrucchi; L. Attard; S. Boccia; P.L. Giacomoni; F. Felline; M. Biselli; E. Loggi; S. Lorenzini; M. Bernardi

Book ID: 117372578
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 165 KB
Volume: 38
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(03)80691-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose IFN-A induction followed by IF

High-dose IFN-A induction followed by IFN plus ribavirin in treatment-naive patients with chronic hepatitis C: A prospective, randomized, controlled trial

✍ Flamm, Steven L.; Conjeevaram, Hari; Wiley, Thelma E.; Ganger, Daniel; O'Riordan 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 357 KB

Randomized, controlled trial with interf

Randomized, controlled trial with interferon-alpha (IFN-alpha) combined with ribavirin with and without amantadine sulfate in primary IFN-alpha nonresponsive patients with chronic hepatitis C

✍ G. Teuber; T. Berg; M. Lafrenz; H. Weidenbach; J. Schoelmerich; P. Wietzke-Braun 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Randomized, controlled trial with IFN-α

Randomized, controlled trial with IFN-α combined with ribavirin with and without amantadine sulphate in non-responders with chronic hepatitis C

✍ Gerlinde Teuber; M Pascu; T Berg; M Lafrenz; J Pausch; F Kullmann; G Ramadori; R 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Multicenter, randomized, double-blind, p

Multicenter, randomized, double-blind, placebo-controlled trial of interferon-a (IFN-a2a) with and without amantadine as treatment for IFN-A non-responders with chronic hepatitis C

✍ Teuber, Gerlinde; Naumann, Uta; Berg, Thomas; Raedle, Jochen; Annette, Dreher 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Pegylated 40KDA IFN alfa-2a plus amantad

Pegylated 40KDA IFN alfa-2a plus amantadine (AMA) or ribavirin (RBV) in naives with chronic hepatitis C (CHC): the HIMPCT (Hepatitis Italian Multicenter Pegasys Amantadine Cooperative Trial)

✍ Gaetano Ideo; Mario Angelico; A. Chirianni; Antonio Craxi; G. Di Perri; L. Minol 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Dally vs. thrice weekly interferon (IFN)

Dally vs. thrice weekly interferon (IFN) in combination with ribavirin (riba)for patients with chronic hepatitis C infection: Preliminary results of a multicenter randomized trial

✍ Kumar, K Shiva; Brown, Melissa; Cerulli, Maurice; Leevy, Carroll; Moskowitz, Sam 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 170 KB